Compare TCRX & UCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TCRX | UCL |
|---|---|---|
| Founded | 2018 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.8M | 10.6M |
| IPO Year | 2021 | 2019 |
| Metric | TCRX | UCL |
|---|---|---|
| Price | $0.14 | $0.22 |
| Analyst Decision | Hold | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $1.00 | N/A |
| AVG Volume (30 Days) | 420.2K | ★ 444.2K |
| Earning Date | 11-12-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 12.28 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,325,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $13.96 |
| P/E Ratio | ★ N/A | $13.72 |
| Revenue Growth | ★ 266.65 | N/A |
| 52 Week Low | $0.14 | $0.15 |
| 52 Week High | $1.47 | $2.38 |
| Indicator | TCRX | UCL |
|---|---|---|
| Relative Strength Index (RSI) | 31.39 | 44.25 |
| Support Level | N/A | $0.21 |
| Resistance Level | $0.21 | $0.25 |
| Average True Range (ATR) | 0.02 | 0.03 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 8.07 | 55.93 |
TScan Therapeutics Inc is a fully integrated clinical-stage biotechnology company focused on developing a robust pipeline of T cell receptor (TCR)-engineered T cell, or TCR-T, therapies for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
Ucloudlink Group Inc is engaged in the provision of data connectivity services and sales of Wi-Fi terminals and data-related products globally. Its uCloudlink cloud SIM platform is designed for shared mobile data connectivity services by allocating the SIM cards remotely and dynamically to users. Ucloudlink's core business is to provide mobile data connectivity services at competitive prices, which it delivers through a range of hardware products and service solutions to its business partners, retail, and enterprise customers. The main hardware terminals offered by the company include portable Wi-Fi terminals, smartphones, and smart-hardware products for international and local mobile data connectivity services. Geographically, it generates maximum revenue from Japan.